Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVDA | Common Stock | Award | $0 | +1.44K | +3.49% | $0.00 | 42.6K | Jun 3, 2022 | Direct | F1 |
transaction | NVDA | Common Stock | Other | $0 | +640 | +1.5% | $0.00 | 43.3K | Jun 3, 2022 | Direct | F2 |
Id | Content |
---|---|
F1 | Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 16, 2022 and 50% of the shares on May 17, 2023. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested. |
F2 | The Form 4 filed by the Reporting Person on February 21, 2020 inadvertently reported a sale of 160 pre-split shares of common stock (640 post-split shares of common stock) from the Reporting Person's direct holdings. These shares were instead sold by a trust, of which Dr. Drell serves as trustee. That trust no longer owns shares of the Issuer's common stock. This Form 4 correctly increases the total amount of shares of common stock directly owned by the Reporting Person by such 640 post-split shares. |